IFNA1 and neoplasm: Natural IFNs were previously used in cancer treatment with limited success, likely because of insufficient drug exposures at the tumor sites due to the short half-lives —indeed, intra-tumoral IFN gene therapy that could deliver high intratumoral IFN levels led to tumor regression [33, 34].